| Name: | Alogliptin Impurity 13 |
| Catalogue No. | VL5900007 |
| CAS No. | 865758-98-1 |
| Molecular Formula | C17H19N5O2 |
| Molecular Weight | 325.37 g/mol |
| Status | In-Stock |
| IUPAC Name | (R)-2-((6-(3-aminopiperidin-1-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile |
| Description | Alogliptin Impurity 13 (CAS No: 865758-98-1) or (R)-2-((6-(3-aminopiperidin-1-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile,Alogliptin Impurity 13 is n impurity of Alogliptin,it is a selective,dipeptidyl peptidase-4 inhibitor that is used to treat hyperglycemia in patients with type 2 diabetes mellitus. |
| References | Kaku, Kohei, et al. “Benefit-Risk Assessment of Alogliptin for the Treatment of Type 2 Diabetes Mellitus.” Drug Safety, vol. 42, no. 11, 25 Oct. 2019, pp. 1311–1327, 10.1007/s40264-019-00857-8. Accessed 1 May 2020. |
